Pharmaceutical Industry

• Nº 1 market for pharmaceuticals in the EU, Nº 3 worldwide
• among top 5 pharmaceutical manufacturing countries, Nº 2 in biopharmaceutical production
• German pharmaceutical production 26.2 billion Euro
• pharmaceuticals total sales: 31.15 billion Euro (domestic 13.56 billion Euro; foreign 17.59 billion Euro); export ratio: 56,1%
• R&D investments: 5.2 billion Euro
• 127,248 employees in pharmaceutical companies

MARKET - Germany is a top location for research, development, manufacturing, and marketing of new active pharmaceutical ingredients. 8,778 pharmaceuticals are registered on the German market.

INDUSTRIAL INFRASTRUCTURE - Our business landscape has a mixed structure and saves room for small family-run entities in the midst of the larger multi-national groups. With an added value of 100,000 Euro per employee, the pharmaceutical industry is among Germany's best-performing industries.

PERSONNEL - Germany has a highly skilled workforce composed of 630,000 doctors and 720,000 engineers, chemists, physicists, and mathematicians. 105,370 graduates in biology, chemistry, medicine, and engineering and the pharmaceutical field are ready to work for you.

R&D - The German pharmaceutical industry is distinguished by a highly innovative environment that places a high value on technology and research resources.  In 2007, Germany ranked only behind the US, with 11,499 patents applications and 4,552 patents granted for pharmaceuticals, as well as 399 biotechnology patents granted. Several universities and research institutes, such as the Fraunhofer and Max Planck Societies, cooperate with companies in discovering new products and bringing them to market.

INCENTIVES - The Federal Ministry of Education and Research has launched a "Pharmaceuticals Initiative for Germany," which entails a general development strategy and targeted support measures for promoting specific products on the way from research to market maturity. The initiative will provide overall funding of more than EUR 800 million before 2011.

PHYSICAL INFRASTRUCTURE - We offer an extensive and comprehensive logistics infrastructure that integrates state-of-the-art transportation networks with the most modern telematics, IT, and telecommunications systems.

STABLE INVESTMENT ENVIRONMENT - Social, economic, and political stability provide a solid base for your corporate projects. Our judiciary and civil services are highly professional. Contractual agreements are secure, and intellectual property is strictly protected in Germany.